Greenwich LifeSciences Secures Approval to Expand GLSI-100's Phase 3 Trial to Europe
Greenwich LifeSciences Secures Approval to Expand GLSI-100's Phase 3 Trial to Europe
格林威治生命科學獲得批准，將 GLSI-100 的 3 期試驗擴展到歐洲
Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.
登入免費觀看全文
登入/註冊